Tickers

1. Composite Trajectory Verdict

Given GXO’s asset-light contract logistics model, the cash flow statement carries the most weight because the business is expected to generate strong free cash flow to service acquisition debt and fund shareholder returns, while the income statement reflects heavy non-cash and one-time charges that obscure operating trends.

Composite Trajectory: Mixed

The annual income statement shows clear deterioration: net income fell 74% year-over-year to $36 million (10-K 2025-12-31, Consolidated Statements of Operations) and 85% from 2023, while operating cash flow dropped 21% to $434 million (10-K 2025-12-31, Consolidated Statements of Cash Flows) and free cash flow contracted to $110 million. The balance sheet reflects higher leverage — total debt rose to $3.065 billion from $2.631 billion (10-K 2025-12-31, Note 10) — and a current ratio below 1.0. Offsetting these, the most recent six-month period shows improvement: operating cash flow rose to $107 million from $32 million (10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows), and pre-tax income swung to $65 million from a $50 million loss (10-Q 2026-06-30, Condensed Consolidated Statements of Operations), though this was aided by the non-recurrence of a $65 million regulatory charge and a $30 million real estate gain.

2. Red Flags

• Net income declined sharply over three years despite revenue growth: $233 million (2023) → $138 million (2024) → $36 million (2025) (10-K 2025-12-31, Consolidated Statements of Operations).
• Operating cash flow declined 21% year-over-year to $434 million (2025) from $549 million (2024) and 22% from $558 million (2023) (10-K 2025-12-31, Consolidated Statements of Cash Flows).
• Free cash flow (operating cash flow minus capex) fell to $110 million in 2025 from $190 million in 2024 and $284 million in 2023 (10-K 2025-12-31, Consolidated Statements of Cash Flows).
• Interest expense rose 29% to $133 million in 2025 from $103 million in 2024, and 151% from $53 million in 2023, driven by acquisition debt (10-K 2025-12-31, Consolidated Statements of Operations).
• Effective tax rate spiked to 65.4% in 2025 from 5.6% in 2024 due to non-deductible regulatory and transaction costs (10-K 2025-12-31, MD&A).
• Regulatory/litigation expense recurred: $65 million in 2025 (Italian VAT matter) and $59 million in 2024 (customer settlement) (10-K 2025-12-31, Consolidated Statements of Operations).
• Net loss on divestiture of $34 million in 2025 and $23 million in H1 2026 related to Wincanton grocery contracts (10-K 2025-12-31, MD&A; 10-Q 2026-06-30, MD&A).
• Current ratio below 1.0: current assets $3.288 billion vs. current liabilities $3.875 billion at December 31, 2025 (10-K 2025-12-31, Consolidated Balance Sheets).
• $400 million of unsecured notes due July 2026 classified as current debt at June 30, 2026 (10-Q 2026-06-30, Consolidated Balance Sheets; 10-Q 2026-06-30, MD&A notes repayment in July 2026).
• Share repurchases of $200 million in 2025 and $18 million in H1 2026 while free cash flow was $110 million and $107 million operating cash flow (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Over the three annual periods provided, revenue grew 35% cumulatively ($9.778 billion to $13.178 billion) but net income fell 85% ($233 million to $36 million) (10-K 2025-12-31, Consolidated Statements of Operations). Operating income declined from $318 million (2023) to $245 million (2025), with operating margin compressing from 3.3% to 1.9%. Direct operating expense as a percentage of revenue worsened from 82.2% (2023) to 84.9% (2025). The six-month 2026 period shows a swing to $65 million pre-tax income from a $50 million loss in 2025, but this reflects the absence of the $65 million regulatory charge and a $30 million real estate benefit; second-quarter 2026 operating income alone was $77 million versus $89 million in Q2 2025 (10-Q 2026-06-30, Condensed Consolidated Statements of Operations). Diluted EPS fell from $1.92 (2023) to $1.12 (2024) to $0.28 (2025) (10-K 2025-12-31, Consolidated Statements of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Annual operating cash flow has declined each year: $558 million (2023) → $549 million (2024) → $434 million (2025) (10-K 2025-12-31, Consolidated Statements of Cash Flows). Capital expenditures remained elevated at $324 million (2025), $359 million (2024), $274 million (2023), resulting in free cash flow of $110 million, $190 million, and $284 million respectively. The six-month 2026 period shows operating cash flow of $107 million versus $32 million in the prior year, but free cash flow remained negative at -$23 million (10-Q 2026-06-30, Condensed Consolidated Statements of Cash Flows). Factoring proceeds contributed $14 million in H1 2026 versus $78 million in H1 2025 (10-Q 2026-06-30, MD&A). Financing cash flows shifted from a $636 million inflow in 2024 (driven by $1.1 billion debt issuance for Wincanton) to a $111 million inflow in 2025 (with $577 million debt issuance offset by $200 million share repurchases and $180 million debt repayment) (10-K 2025-12-31, Consolidated Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Total assets grew to $12.262 billion at December 31, 2025 from $11.266 billion a year earlier, driven by goodwill ($3.781 billion vs. $3.549 billion) and operating lease assets ($2.563 billion vs. $2.329 billion) (10-K 2025-12-31, Consolidated Balance Sheets). Cash increased to $854 million from $413 million, but total debt rose to $3.065 billion from $2.631 billion (10-K 2025-12-31, Note 10). The current portion of debt jumped to $446 million from $110 million due to the $400 million notes due July 2026 (10-K 2025-12-31, Consolidated Balance Sheets). At June 30, 2026, cash declined to $769 million and current debt rose to $751 million following reclassification of the five-year term loan ($275 million) and the 2026 notes ($400 million) (10-Q 2026-06-30, Consolidated Balance Sheets). Total equity was essentially flat at $3.015 billion versus $3.035 billion, while the current ratio remained below 1.0 (0.85 at both year-end 2025 and June 2026) (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Consolidated Balance Sheets).

6. Data Gaps

• Full 2023 balance sheet (total assets, total liabilities, total debt) not provided in the 10-K excerpt; only cash and selected figures appear.
• Quarterly income statements for Q1 2026 and Q1 2025 not provided; only Q2 and year-to-date figures are available.
• Organic revenue growth rate (excluding acquisitions and FX) not explicitly disclosed for annual periods; MD&A cites $655 million from Wincanton and $352 million FX for 2025 but no standalone organic figure.
• Segment-level operating profitability not reported; the company aggregates three operating segments into one reportable segment (10-K 2025-12-31, Note 4).
• Forward-looking guidance or covenant compliance metrics beyond the stated leverage ratio compliance (10-K 2025-12-31, Note 10).
• Detailed breakdown of the $30 million real estate benefit in H1 2026 (10-Q 2026-06-30, MD&A).